Indication Bloat – The Next DTC Issue
What If There Were No DTC?When I posed this question to members of the PHARMA-MKTING online discussion group it resulted in a flurry of...
Deconstructing Frist on DTC
Last week Senate Majority Leader Bill Frist, (R., Tenn.) shocked the pharma and advertising industries by calling for pharma to ban DTC advertising for...
To Ban or Not to Ban DTC, That is the Question
The pharmaceutical industry must be reeling from the blow just recently delivered by Senate Majority Leader Bill Frist (R-TN) who called upon the drug...
DTC – Best of Times, Worst of Times
Chairman Bob (Bob Ehrlich over at DTC Perspectives), in stiff upper-lip fashion, predicts that the "best is yet to come" for DTC marketers. Au...
Restrict DTC, but Extend the Patent for New Drugs
When the leading Republican member of Congress and a contender for the next president of the United States says it's time for the pharmaceutical industry to 'clean up it's act' and suggests banning DTC advertising of new drugs for 2 years after launch, you know that you are in trouble. Should the industry fight back or 'suffer the slings and arrows of politicians' until it all blows over? If it fights back, how should it fight back?
A Call to Action: A Mea Non Culpa by Big Pharma
A review of the book 'A Call to Action' by Pfizer CEO Dr. Hank McKinnell. This review focuses on the 10 action items McKinnell promulgates. Notwithstanding an Amazon.com review of the book written by Peter Rost -- Pfizer's whistleblowing head of endocrine care marketing unit -- in which McKinnell is described as making 'an impressive mea culpa,' this book is actually a mea non culpa! Find out why..
Translate Industry Trends into the Optimal Promotional Strategy
This is a summary of a recent presentation by David L. Stern, Vice President of Marketing for Metabolic and Endocrinology at Serono, Inc. Stern spoke from a marketer's perspective about recent trends in the pharmaceutical industry and how to address them by developing better marketing programs.
Marketing the Pharma Industry: The Empire Strikes Back
This article gives a spirited review of a recent Pharmaceutical Marketers Knowledgeshare Forum and includes a composite overview of the action plan developed by attendees for the pharma industry to regain trust.
To Ban or Not to Ban DTC? That Was the Question!
This article takes a critical look at Sen. Frist's proposal to reform DTC. The article includes reactions to the Frist proposal from PhRMA, AMA, advertising trade associations, and from members of the PHARMA-MKTING online discussion group.
Pharma eMarketing at Tipping Point?
Last week's ePharma Summit was held at the new Borgata Hotel and Casino in Atlantic City, NJ. This venue, it turns out, was appropriate...
